Renal Cancer - Results from #580

Treatment Landscape of Renal Cell Carcinoma. December 29, 2023

Short- and Long-Term Renal Function After Partial Nephrectomy: Comparison of Solitary and Multifocal Renal Masses. December 29, 2023

Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. December 28, 2023

Functional recovery after partial nephrectomy in a solitary kidney. December 28, 2023

Early Evolution in Cancer: A Mathematical Support for Pathological and Genomic Evidence in Clear Cell Renal Cell Carcinoma. December 27, 2023

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma. December 27, 2023

Correlation between bilateral GFR in patients with localized renal cancer after partial nephrectomy. December 26, 2023

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma. December 26, 2023

Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy. December 25, 2023

Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features. December 25, 2023

Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer. December 22, 2023

A Literature Review of Perioperative Outcomes of Robotic Radical Nephrectomy (RRN) Versus Laparoscopic Radical Nephrectomy (LRN) for Renal Cell Carcinoma (RCC). December 22, 2023

The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential. December 21, 2023

Multimodal deep learning for personalized renal cell carcinoma prognosis: Integrating CT imaging and clinical data. December 21, 2023

Diversity in Renal Mass Data Cohorts: Implications for Urology AI Researchers. December 20, 2023

Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART). December 20, 2023

Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study. December 19, 2023

Molecular Characterization of TFE3-rearranged Renal Cell Carcinoma, A Comparative Study with Papillary and Clear Cell Renal Cell Carcinomas. December 19, 2023

Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence. December 18, 2023

Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. December 18, 2023

Page 30 of 456